{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:06:54Z","timestamp":1784279214070,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Special Funds for Scientific Research on Breast Diseases of Shandong Medical Association","award":["No. YXH2021ZX058"],"award-info":[{"award-number":["No. YXH2021ZX058"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81970347"],"award-info":[{"award-number":["No. 81970347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Co-innovation center of classic TCM formula"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05589-9","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:19:09Z","timestamp":1780906749000},"page":"3137-3150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulated KIF2A correlates with p53 expression pattern in breast cancer"],"prefix":"10.1007","volume":"481","author":[{"given":"Yun","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"5589_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"5589_CR2","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR et al (2008) Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26:1275\u20131281. https:\/\/doi.org\/10.1200\/JCO.2007.14.4147","journal-title":"J Clin Oncol"},{"key":"5589_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002036","volume":"9","author":"Q Klopfenstein","year":"2021","unstructured":"Klopfenstein Q, Derang\u00e8re V, Arnould L et al (2021) Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer. J Immunother Cancer 9:e002036. https:\/\/doi.org\/10.1136\/jitc-2020-002036","journal-title":"J Immunother Cancer"},{"key":"5589_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tcb.2005.07.006","volume":"15","author":"H Miki","year":"2005","unstructured":"Miki H, Okada Y, Hirokawa N (2005) Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 15:467\u2013476. https:\/\/doi.org\/10.1016\/j.tcb.2005.07.006","journal-title":"Trends Cell Biol"},{"key":"5589_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.785981","volume":"12","author":"J Yang","year":"2022","unstructured":"Yang J, Wu Z, Yang L et al (2022) Characterization of kinesin family member 2C as a proto-oncogene in cervical cancer. Front Pharmacol 12:785981. https:\/\/doi.org\/10.3389\/fphar.2021.785981","journal-title":"Front Pharmacol"},{"key":"5589_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/1759-7714.13051","volume":"10","author":"X Li","year":"2019","unstructured":"Li X, Liu M, Zhang Z et al (2019) High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma. Thorac Cancer 10:1103\u20131110. https:\/\/doi.org\/10.1111\/1759-7714.13051","journal-title":"Thorac Cancer"},{"key":"5589_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neo.2014.03.008","volume":"16","author":"SM Singel","year":"2014","unstructured":"Singel SM, Cornelius C, Zaganjor E et al (2014) KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer. Neoplasia 16:247-256.e2. https:\/\/doi.org\/10.1016\/j.neo.2014.03.008","journal-title":"Neoplasia"},{"key":"5589_CR8","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1091\/mbc.E07-02-0110","volume":"18","author":"AL Manning","year":"2007","unstructured":"Manning AL, Ganem NJ, Bakhoum SF et al (2007) The kinesin-13 proteins Kif2a, Kif2b, and Kif2c\/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell 18:2970\u20132979. https:\/\/doi.org\/10.1091\/mbc.E07-02-0110","journal-title":"Mol Biol Cell"},{"key":"5589_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2018.02.020","volume":"497","author":"T Xie","year":"2018","unstructured":"Xie T, Li X, Ye F et al (2018) High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma. Biochem Biophys Res Commun 497:65\u201372. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.020","journal-title":"Biochem Biophys Res Commun"},{"key":"5589_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109840","volume":"125","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang Y, Liu X et al (2020) KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer. Biomed Pharmacother 125:109840. https:\/\/doi.org\/10.1016\/j.biopha.2020.109840","journal-title":"Biomed Pharmacother"},{"key":"5589_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23135","volume":"34","author":"G Wang","year":"2020","unstructured":"Wang G, Wang Z, Yu H (2020) Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients. J Clin Lab Anal 34:e23135. https:\/\/doi.org\/10.1002\/jcla.23135","journal-title":"J Clin Lab Anal"},{"key":"5589_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-461","volume":"14","author":"J Wang","year":"2014","unstructured":"Wang J, Ma S, Ma R et al (2014) KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer. BMC Cancer 14:461. https:\/\/doi.org\/10.1186\/1471-2407-14-461","journal-title":"BMC Cancer"},{"key":"5589_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.cdd.4401938","volume":"13","author":"AW Braithwaite","year":"2006","unstructured":"Braithwaite AW, Prives CL (2006) p53: more research and more questions. Cell Death Differ 13:877\u2013880. https:\/\/doi.org\/10.1038\/sj.cdd.4401938","journal-title":"Cell Death Differ"},{"key":"5589_CR14","doi-asserted-by":"publisher","unstructured":"Koboldt DC, Fulton RS, McLellan MD, et al (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61\u201370. https:\/\/doi.org\/10.1038\/nature11412","DOI":"10.1038\/nature11412"},{"key":"5589_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y (2023) Targeting p53 pathways: mechanisms, structures and advances in therapy. Signal Transduct Target Ther 8:92. https:\/\/doi.org\/10.1038\/s41392-023-01347-1","journal-title":"Signal Transduct Target Ther"},{"key":"5589_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5448","volume":"55","author":"ML Tornesello","year":"2024","unstructured":"Tornesello ML (2024) TP53 mutations in cancer: molecular features and therapeutic opportunities (Review). Int J Mol Med 55:7. https:\/\/doi.org\/10.3892\/ijmm.2024.5448","journal-title":"Int J Mol Med"},{"key":"5589_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10549-024-07357-z","volume":"207","author":"SA Anderson","year":"2024","unstructured":"Anderson SA, Bartow BB, Harada S et al (2024) p53 protein expression patterns associated with TP53 mutations in breast carcinoma. Breast Cancer Res Treat 207:213\u2013222. https:\/\/doi.org\/10.1007\/s10549-024-07357-z","journal-title":"Breast Cancer Res Treat"},{"key":"5589_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/oncolo\/oyad309","volume":"29","author":"G Dajti","year":"2023","unstructured":"Dajti G, Serra M, Cisternino G et al (2023) Prognostic role of p53 immunohistochemical status in invasive breast cancer. A retrospective review of 1387 cases with luminal-like\/Her2 negative breast tumors. Oncologist 29:384\u2013391. https:\/\/doi.org\/10.1093\/oncolo\/oyad309","journal-title":"Oncologist"},{"key":"5589_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.5375","volume":"250","author":"N Singh","year":"2020","unstructured":"Singh N, Piskorz AM, Bosse T et al (2020) p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol 250:336\u2013345. https:\/\/doi.org\/10.1002\/path.5375","journal-title":"J Pathol"},{"key":"5589_CR20","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.7150\/jca.52103","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Yang L, Xiong L et al (2021) KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53\/GSK3\u03b2 signaling. J Cancer 12:3741\u20133753. https:\/\/doi.org\/10.7150\/jca.52103","journal-title":"J Cancer"},{"key":"5589_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1083\/jcb.200711032","volume":"181","author":"C-Y Jang","year":"2008","unstructured":"Jang C-Y, Wong J, Coppinger JA et al (2008) DDA3 recruits microtubule depolymerase Kif2a to spindle poles and controls spindle dynamics and mitotic chromosome movement. J Cell Biol 181:255\u2013267. https:\/\/doi.org\/10.1083\/jcb.200711032","journal-title":"J Cell Biol"},{"key":"5589_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J (2016) The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 6:a026104. https:\/\/doi.org\/10.1101\/cshperspect.a026104","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5589_CR23","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3892\/ol.2015.3461","volume":"10","author":"J Sun","year":"2015","unstructured":"Sun J, Chen C, Wei W et al (2015) Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: a population-based study. Oncol Lett 10:1741\u20131748. https:\/\/doi.org\/10.3892\/ol.2015.3461","journal-title":"Oncol Lett"},{"key":"5589_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103438","volume":"87","author":"C Liu","year":"2025","unstructured":"Liu C, Shi J, Wang F et al (2025) Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort study. eClinicalMedicine 87:103438. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103438","journal-title":"eClinicalMedicine"},{"key":"5589_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.emboj.7600076","volume":"23","author":"P Holmfeldt","year":"2004","unstructured":"Holmfeldt P, Stenmark S, Gullberg M (2004) Differential functional interplay of TOGp\/XMAP215 and the KinI kinesin MCAK during interphase and mitosis. EMBO J 23:627\u2013637. https:\/\/doi.org\/10.1038\/sj.emboj.7600076","journal-title":"EMBO J"},{"key":"5589_CR26","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1091\/mbc.E01-12-0143","volume":"13","author":"SL Kline-Smith","year":"2002","unstructured":"Kline-Smith SL, Walczak CE (2002) The microtubule-destabilizing kinesin XKCM1 regulates microtubule dynamic instability in cells. Mol Biol Cell 13:2718\u20132731. https:\/\/doi.org\/10.1091\/mbc.E01-12-0143","journal-title":"Mol Biol Cell"},{"key":"5589_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.bjc.6603905","volume":"97","author":"Y Nakamura","year":"2007","unstructured":"Nakamura Y, Tanaka F, Haraguchi N et al (2007) Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 97:543\u2013549. https:\/\/doi.org\/10.1038\/sj.bjc.6603905","journal-title":"Br J Cancer"},{"key":"5589_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27528-6","volume":"12","author":"M Sun","year":"2021","unstructured":"Sun M, Jia M, Ren H et al (2021) NuMA regulates mitotic spindle assembly, structural dynamics and function via phase separation. Nat Commun 12:7157. https:\/\/doi.org\/10.1038\/s41467-021-27528-6","journal-title":"Nat Commun"},{"key":"5589_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/02841860802047411","volume":"47","author":"J Alsner","year":"2008","unstructured":"Alsner J, Jensen V, Kyndi M et al (2008) A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients. Acta Oncol 47:600\u2013607. https:\/\/doi.org\/10.1080\/02841860802047411","journal-title":"Acta Oncol"},{"key":"5589_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/PAI.0000000000001144","volume":"31","author":"AM Bellizzi","year":"2023","unstructured":"Bellizzi AM (2023) p53 as exemplar next-generation immunohistochemical marker: a molecularly informed, pattern-based approach, methodological considerations, and pan-cancer diagnostic applications. Appl Immunohistochem Mol Morphol: AIMM 31:507\u2013530. https:\/\/doi.org\/10.1097\/PAI.0000000000001144","journal-title":"Appl Immunohistochem Mol Morphol: AIMM"},{"key":"5589_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jmcb\/mjz067","volume":"11","author":"J Bargonetti","year":"2019","unstructured":"Bargonetti J, Prives C (2019) Gain-of-function mutant p53: history and speculation. J Mol Cell Biol 11:605\u2013609. https:\/\/doi.org\/10.1093\/jmcb\/mjz067","journal-title":"J Mol Cell Biol"},{"key":"5589_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063187","volume":"8","author":"M Fischer","year":"2013","unstructured":"Fischer M, Grundke I, Sohr S et al (2013) p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes. PLOS One 8:e63187. https:\/\/doi.org\/10.1371\/journal.pone.0063187","journal-title":"PLOS One"},{"key":"5589_CR33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/dneu.20802","volume":"70","author":"C-N Sun","year":"2010","unstructured":"Sun C-N, Chuang H-C, Wang J-Y et al (2010) The A2A adenosine receptor rescues neuritogenesis impaired by p53 blockage via KIF2A, a kinesin family member. Dev Neurobiol 70:604\u2013621. https:\/\/doi.org\/10.1002\/dneu.20802","journal-title":"Dev Neurobiol"},{"key":"5589_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003193118","volume":"118","author":"L Chibaya","year":"2021","unstructured":"Chibaya L, Karim B, Zhang H, Jones SN (2021) Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. Proc Natl Acad Sci U S A 118:e2003193118. https:\/\/doi.org\/10.1073\/pnas.2003193118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5589_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41556-022-00949-1","volume":"24","author":"M Chen","year":"2022","unstructured":"Chen M, Choi S, Wen T et al (2022) A p53\u2013phosphoinositide signalosome regulates nuclear AKT activation. Nat Cell Biol 24:1099\u20131113. https:\/\/doi.org\/10.1038\/s41556-022-00949-1","journal-title":"Nat Cell Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05589-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:24:06Z","timestamp":1784276646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05589-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5589"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05589-9","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Qilu Hospital of Shandong University.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual patients included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final manuscript.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}